LONDON and CAMBRIDGE, MA--(Marketwire - April 16, 2008) - InforSense Ltd., the leading provider of embedded enterprise intelligence, today announced that it has signed a three year collaboration agreement with Dana-Farber Cancer Institute. The deal includes InforSense’s ClinicalSense cohort selection and clinical decision support product, and its wider translational research capabilities to support improved disease understanding and patient care in oncology.
